IBU-TEC ADVANCED MATERIALS A (IBU.DE) Stock Fundamental Analysis

FRA:IBU • DE000A0XYHT5

17.65 EUR
-0.25 (-1.4%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

4

Overall IBU gets a fundamental rating of 4 out of 10. We evaluated IBU against 66 industry peers in the Chemicals industry. While IBU has a great health rating, there are worries on its profitability. While showing a medium growth rate, IBU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • IBU had negative earnings in the past year.
  • In the past year IBU had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: IBU reported negative net income in multiple years.
  • In multiple years IBU reported negative operating cash flow during the last 5 years.
IBU.DE Yearly Net Income VS EBIT VS OCF VS FCFIBU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • IBU has a worse Return On Assets (-4.02%) than 74.24% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.46%, IBU is doing worse than 71.21% of the companies in the same industry.
Industry RankSector Rank
ROA -4.02%
ROE -5.46%
ROIC N/A
ROA(3y)-3.09%
ROA(5y)-1.54%
ROE(3y)-4.18%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
IBU.DE Yearly ROA, ROE, ROICIBU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • Looking at the Gross Margin, with a value of 52.84%, IBU is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
  • IBU's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for IBU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.97%
GM growth 5Y-1.86%
IBU.DE Yearly Profit, Operating, Gross MarginsIBU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

  • IBU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IBU remains at a similar level compared to 1 year ago.
  • IBU has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for IBU has been reduced compared to a year ago.
IBU.DE Yearly Shares OutstandingIBU.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IBU.DE Yearly Total Debt VS Total AssetsIBU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • IBU has an Altman-Z score of 3.82. This indicates that IBU is financially healthy and has little risk of bankruptcy at the moment.
  • IBU has a Altman-Z score of 3.82. This is amongst the best in the industry. IBU outperforms 80.30% of its industry peers.
  • IBU has a debt to FCF ratio of 2.93. This is a good value and a sign of high solvency as IBU would need 2.93 years to pay back of all of its debts.
  • The Debt to FCF ratio of IBU (2.93) is better than 86.36% of its industry peers.
  • A Debt/Equity ratio of 0.17 indicates that IBU is not too dependend on debt financing.
  • IBU has a better Debt to Equity ratio (0.17) than 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.93
Altman-Z 3.82
ROIC/WACCN/A
WACC7.23%
IBU.DE Yearly LT Debt VS Equity VS FCFIBU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 8.03 indicates that IBU has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 8.03, IBU belongs to the top of the industry, outperforming 98.48% of the companies in the same industry.
  • IBU has a Quick Ratio of 3.15. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.15, IBU belongs to the top of the industry, outperforming 93.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.03
Quick Ratio 3.15
IBU.DE Yearly Current Assets VS Current LiabilitesIBU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 53.84% over the past year.
  • The Revenue has decreased by -6.21% in the past year.
  • The Revenue has been growing slightly by 0.88% on average over the past years.
EPS 1Y (TTM)53.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.21%
Revenue 1Y (TTM)-6.21%
Revenue growth 3Y4.71%
Revenue growth 5Y0.88%
Sales Q2Q%-23.52%

3.2 Future

  • IBU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.60% yearly.
  • Based on estimates for the next years, IBU will show a very strong growth in Revenue. The Revenue will grow by 20.92% on average per year.
EPS Next Y91.04%
EPS Next 2Y38.35%
EPS Next 3Y28.6%
EPS Next 5YN/A
Revenue Next Year-11.39%
Revenue Next 2Y-6.18%
Revenue Next 3Y3.54%
Revenue Next 5Y20.92%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IBU.DE Yearly Revenue VS EstimatesIBU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 2031 50M 100M 150M
IBU.DE Yearly EPS VS EstimatesIBU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

  • IBU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IBU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBU.DE Price Earnings VS Forward Price EarningsIBU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • IBU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. IBU is more expensive than 72.73% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IBU is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.27
EV/EBITDA 32.39
IBU.DE Per share dataIBU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • IBU's earnings are expected to grow with 28.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.35%
EPS Next 3Y28.6%

1

5. Dividend

5.1 Amount

  • IBU has a yearly dividend return of 0.18%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.13, IBU is paying slightly less dividend.
  • With a Dividend Yield of 0.18, IBU pays less dividend than the S&P500 average, which is at 1.85.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IBU.DE Yearly Dividends per shareIBU.DE Yearly Dividends per shareYearly Dividends per share 2019 2023 0.05 0.1 0.15

5.3 Sustainability

DP0%
EPS Next 2Y38.35%
EPS Next 3Y28.6%
IBU.DE Yearly Income VS Free CF VS DividendIBU.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

IBU-TEC ADVANCED MATERIALS A

FRA:IBU (2/20/2026, 7:00:00 PM)

17.65

-0.25 (-1.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-27
Earnings (Next)04-13
Inst Owners2.04%
Inst Owner ChangeN/A
Ins Owners48.12%
Ins Owner ChangeN/A
Market Cap83.84M
Revenue(TTM)44.78M
Net Income(TTM)-2.78M
Analysts83.33
Price Target28.25 (60.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)31.9%
PT rev (3m)264.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)82.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.87
P/FCF 29.27
P/OCF 10.58
P/B 1.65
P/tB 1.82
EV/EBITDA 32.39
EPS(TTM)-0.58
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.6
FCFY3.42%
OCF(TTM)1.67
OCFY9.45%
SpS9.43
BVpS10.69
TBVpS9.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.02%
ROE -5.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.84%
FCFM 6.4%
ROA(3y)-3.09%
ROA(5y)-1.54%
ROE(3y)-4.18%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.97%
GM growth 5Y-1.86%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.93
Debt/EBITDA 2.96
Cap/Depr 113.35%
Cap/Sales 11.3%
Interest Coverage N/A
Cash Conversion 279.37%
Profit Quality N/A
Current Ratio 8.03
Quick Ratio 3.15
Altman-Z 3.82
F-Score6
WACC7.23%
ROIC/WACCN/A
Cap/Depr(3y)170.7%
Cap/Depr(5y)144.35%
Cap/Sales(3y)15.86%
Cap/Sales(5y)13.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.21%
EPS Next Y91.04%
EPS Next 2Y38.35%
EPS Next 3Y28.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.21%
Revenue growth 3Y4.71%
Revenue growth 5Y0.88%
Sales Q2Q%-23.52%
Revenue Next Year-11.39%
Revenue Next 2Y-6.18%
Revenue Next 3Y3.54%
Revenue Next 5Y20.92%
EBIT growth 1Y64.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.13%
EBIT Next 3Y59.66%
EBIT Next 5YN/A
FCF growth 1Y122.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2881.05%
OCF growth 3YN/A
OCF growth 5Y17.1%

IBU-TEC ADVANCED MATERIALS A / IBU.DE FAQ

Can you provide the ChartMill fundamental rating for IBU-TEC ADVANCED MATERIALS A?

ChartMill assigns a fundamental rating of 4 / 10 to IBU.DE.


What is the valuation status for IBU stock?

ChartMill assigns a valuation rating of 2 / 10 to IBU-TEC ADVANCED MATERIALS A (IBU.DE). This can be considered as Overvalued.


How profitable is IBU-TEC ADVANCED MATERIALS A (IBU.DE) stock?

IBU-TEC ADVANCED MATERIALS A (IBU.DE) has a profitability rating of 1 / 10.


How financially healthy is IBU-TEC ADVANCED MATERIALS A?

The financial health rating of IBU-TEC ADVANCED MATERIALS A (IBU.DE) is 8 / 10.